{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-4853", "FDA", "Requests that the FDA issue a declaration permitting the submission of an Abbreviated New Drug Application (ANDA) for Trazodone Hydrochloride Tablets, USP 200 mg strength", "Nonrulemaking", "2026-05-05T19:48:22Z", "0b000064b92c2626"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-4853"], "units": {}, "query_ms": 0.4017759929411113, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}